2018年美國糖尿病學會計對糖尿病視網膜病變之標準治療建議

10.6666/ClinMed.201808_82(2).0083

郝立智；張雅椅；鄭嘉偉；周俐禎；潘潔慧；王志龍；楊純宜；周劍文；陳昆祥；李尹暘

糖尿病( diabetes mellitus , DM) ； 美國糖尿病學會(American Diabetes Association, ADA) ； 增殖性糖尿病視網膜病變(proliferative diabetic retinopathy, PDR ) ； 抗血管內皮生長因子(anti-vascular endothelial growth factor, anti- VEGF)

臨床醫學月刊

82卷2期（2018 / 08 / 31）

454 - 462

繁體中文

與全視網膜雷射光凝術療法和傳統標準治療相比較，本次標準治療在增殖性糖尿病視網膜病變(PDR)患者使用抗血管內皮生長因子ranibizumab以降低患者視力喪失的風險的非劣效性方面增加了新的建議。玻璃體內注射抗血管內皮生長因子ranibizumab並不劣於傳統的全視網膜雷射光光凝治療，還可以降低PDR患者視力喪失的風險。玻璃體內注射抗血管內皮生長因子可用於中心型糖尿病性黃斑水腫。視網膜病變的存在不是阿司匹林治療心臟保護的禁忌症。應及時將具有任何程度的黃斑水腫、嚴重的非PDR或任何PDR的患者轉診給在糖尿病視網膜病變處理方面具有豐富知識和經驗的眼科醫師。

1. (2018)。全民健康保險藥品給付規定修正（106年12月1日生效）第14節眼科製劑Ophthalmic preparations 14.9.2. 新生血管抑制劑（Anti-angiogenic agents）。三總藥訊，1，8-9。
2. Agardh, E,Tababat-Khani, P(2011).Adopting 3-year screening intervals for sight-threatening retinal vascular lesions in type 2 diabetic subjects without retinopathy.Diabetes Care,34,1318-1319.
3. Ahmed, J,Ward, TP,Bursell, S-E(2006).The sensitivity and specificity of nonmydriatic digital stereoscopic retinal imaging in detecting diabetic retinopathy.Diabetes Care,29,2205-2209.
4. American Diabetes Association(2018).10. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2018.Diabetes Care,41,S105-S118.
5. American Diabetes Association(2009).Standards of medical care in diabetes(Position Statement).Diabetes Care,28,S13-S31.
6. Axer-Siegel, R,Hod, M,Fink-Cohen, S(1996).Diabetic retinopathy during pregnancy.Ophthalmology,103,1815-1819.
7. Best, RM,Chakravarthy, U.(1997).Diabetic retinopathy in pregnancy.Br J Ophthalmol,81,249-251.
8. Bragge, P,Gruen, RL,Chau, M(2011).Screening for presence or absence of diabetic retinopathy: a meta-analysis.Arch Ophthalmol,129,435-444.
9. Chew, EY,Ambrosius, WT,Davis, MD(2010).ACCORD Study Group; ACCORD Eye Study Group. Effects of medical therapies on retinopathy progression in type 2 diabetes.N Engl J Med,363,233-244.
10. Chew, EY,Davis, MD,Danis, RP(2014).The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes(ACCORD) Eye Study.Ophthalmology,121,2443-2451.
11. Dabelea, D,Stafford, JM,Mayer-Davis, EJ(2017).SEARCH for Diabetes in Youth Research Group. Association of type 1 diabetes vs type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood.JAMA,317,825-835.
12. Diabetes Control and Complications Trial Research Group(2000).Effect of pregnancy on microvascular complications in the Diabetes Control and Complications Trial.Diabetes Care,23,1084-1091.
13. Early Treatment Diabetic Retinopathy Study Research Group(1985).Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1.Arch Ophthalmol,103,1796-1806.
14. Elman, MJ,Aiello, LP,Beck, RW(2010).Diabetic Retinopathy Clinical Research Network. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.Ophthalmology,117,1064-1077.e35.
15. Elman, MJ,Bressler, NM,Qin, H(2011).Diabetic Retinopathy Clinical Research Network. Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.Ophthalmology,118,609-614.
16. Estacio, RO,McFarling, E,Biggerstaff, S,Jeffers, BW,Johnson, D,Schrier, RW(1998).Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM.Am J Kidney Dis,31,947-953.
17. Fong, DS,Aiello, LP,Ferris, FL(2004).Diabetic retinopathy.Diabetes Care,27,2540-2553.
18. Gross, JG,Glassman, AR,Jampol, LM(2015).Writing Committee for the Diabetic Retinopathy Clinical Research Network. Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial.JAMA,314,2137-2146.
19. Gubitosi-Klug, RA,Sun, W,Cleary, PA(2016).Writing Team for the DCCT/EDIC Research Group. Effects of prior intensive insulin therapy and risk factors on patient-reported visual function outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications(DCCT/EDIC) cohort.JAMA Ophthalmol,134,137-145.
20. Gunderson, EP,Lewis, CE,Tsai, A-L(2007).A 20-year prospective study of childbearing and incidence of diabetes in young women, controlling for glycemia before conception: the Coronary Artery Risk Development in Young Adults(CARDIA) Study.Diabetes,56,2990-2996.
21. Hooper, P,Boucher, MC,Cruess, A(2012).Canadian Ophthalmological Society evidence-based clinical practice guidelines for the management of diabetic retinopathy.Can J Ophthalmol,47,S1-S30.
22. Klein, R(1995).Hyperglycemia and microvascular and macrovascular disease in diabetes.Diabetes Care,18,258-268.
23. Leske, MC,Wu, S-Y,Hennis, A(2005).Barbados Eye Study Group. Hyperglycemia, blood pressure, and the 9-year incidence of diabetic retinopathy: the Barbados Eye Studies.Ophthalmology,112,799-805.
24. Mitchell, P,Bandello, F,Schmidt-Erfurth, U(2011).RESTORE Study Group. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.Ophthalmology,118,615-625.
25. Nathan, DM,Bebu, I,Hainsworth, D(2017).DCCT/EDIC Research Group. Frequency of evidence-based screening for retinopathy in type 1 diabetes.N Engl J Med,376,1507-1516.
26. Nathan, DM,Genuth, S,Lachin, J,Diabetes Control and Complications Trial Research Group(1993).The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus.N Engl J Med,329,977-986.
27. Nguyen, QD,Brown, DM,Marcus, DM(2012).RISE and RIDE Research Group. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.Ophthalmology,119,789-801.
28. Shih, C-J,Chen, H-T,Kuo, S-C(2016).Comparative effectiveness of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers in patients with type 2 diabetes and retinopathy.CMAJ,188,E148-E157.
29. Solomon, SD,Chew, E,Duh, EJ(2017).Diabetic retinopathy: a position statement by the American Diabetes Association.Diabetes Care,40,412-418.
30. The Diabetic Retinopathy Study Research Group(1976).Preliminary report on effects of photocoagulation therapy.Am J Ophthalmol,81,383-396.
31. Walton, OB,Garoon, RB,Weng, CY(2016).Evaluation of automated teleretinal screening program for diabetic retinopathy.JAMA Ophthalmol,134,204-209.